Associated Papers
Partial nonstructural 3 region analysis of hepatitis C virus genotype 3a.
Kiattanaphon A et al.
Molecular Biology Reports, 2022
Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a.
Guo Z et al.
The Journal of Biological Chemistry, 2017
Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C.
Sargin Altunok E et al.
International Journal of Infectious Diseases : Ijid : Official Publication of the International Society for Infectious Diseases, 2016
Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy.
Abdel-Hameed EA et al.
Viral Immunology, 2016
Characterization of hepatitis C virus (HCV) quasispecies dynamics upon short-term dual therapy with the HCV NS5B nucleoside polymerase inhibitor mericitabine and the NS3/4 protease inhibitor danoprevir.
Le Pogam S et al.
Antimicrobial Agents and Chemotherapy, 2012
Select a paper to view details